Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis

Reid, P. A., McAllister, D. A. , Boyd, A. C., Innes, J. A., Porteous, D., Greening, A. P. and Gray, R. D. (2015) Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 191(2), pp. 233-236. (doi: 10.1164/rccm.201407-1365LE) (PMID:25590159) (PMCID:PMC4347434)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McAllister, Professor David
Authors: Reid, P. A., McAllister, D. A., Boyd, A. C., Innes, J. A., Porteous, D., Greening, A. P., and Gray, R. D.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Public Health
Journal Name:American Journal of Respiratory and Critical Care Medicine
Publisher:American Thoracic Society
ISSN:1073-449X
ISSN (Online):1535-4970

University Staff: Request a correction | Enlighten Editors: Update this record